Evidence map›Paper›PMID 41323178›Full record

ArticleRadiology case reports2026

Hepatic artery pseudoaneurysms: Two cases, 2 novel solutions, and a brief review of current treatments.

John Cacciatore, Stephanie Gonzalez, Kenneth Briley, Syed Ali, Maria Del Pilar Bayona Molano, Neal Viradia

Abstract readCase Reports
In one paragraph

Article in Radiology case reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

John CacciatoreUniversity of Miami, Miller School of Medicine, Miami, FL, USA.
Stephanie GonzalezUniversity of Miami, Miller School of Medicine, Miami, FL, USA.
Kenneth BrileyUniversity of Miami, Miller School of Medicine, Miami, FL, USA.
Syed AliUniversity of Miami, Miller School of Medicine, Miami, FL, USA.
Maria Del Pilar Bayona MolanoUniversity of Miami, Miller School of Medicine, Miami, FL, USA.
Neal ViradiaUniversity of Miami, Miller School of Medicine, Miami, FL, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Despite their rarity, hepatic artery pseudoaneurysms present a major risk to patients associated with high mortality. Effective, timely treatment is crucial. Options include percutaneous, endovascular, and surgical management. The first case involved a 68-year-old female with a fusiform pseudoaneurysm at the bifurcation of the common hepatic into the proper hepatic artery and the gastroduodenal arteries. Onyx (ev3,Plymouth,MN) was used to reconstruct the vessel lumen while angiography confirmed embolization of the pseudoaneurysm and arterial patency. Postoperatively, the Hgb stabilized with discharge 5 days later. The second case involved a 45-year-old male with nausea, emesis, pain, elevated liver function tests, and a pseudoaneurysm of the proper hepatic artery seen on imaging. Balloon occlusion was performed for 50 minutes until complete thrombosis. This method was only feasible due to the dual blood supply of the liver. Postoperatively, the abdominal pain immediately resolved and liver enzymes returned to baseline with discharge 2 days later. Being both rare and deadly, effective treatments of hepatic artery pseudoaneurysms are necessary, but novel treatments are seldom documented. Here 2 cases are described: vessel reconstruction with Onyx and Prolonged Balloon Occlusion. Both proved to be effective. Future studies should investigate additional options.

Indexed as

Balloon occlusionEmbolizationEndovascularHepatic artery pseudoaneurysm

Identifiers

PMID41323178
PMCPMC12661396

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.